Nektar Therapeutics (NKTR)
81.89
-1.48
(-1.78%)
USD |
NASDAQ |
May 08, 16:00
80.51
-1.38
(-1.69%)
After-Hours: 20:00
Nektar Therapeutics Shareholders Equity (Quarterly) : 576.22M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.20B |
| Aquestive Therapeutics, Inc. | -33.66M |
| Boston Scientific Corp. | 25.86B |
| Esperion Therapeutics, Inc. | -301.96M |
| Corcept Therapeutics, Inc. | 637.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.27M |
| Total Liabilities (Quarterly) | 187.06M |
| Debt to Equity Ratio | 0.2489 |
| Current Ratio | 10.21 |
| Net Debt Paydown Yield | 0.82% |